Phosphoproteomics for oncology discovery and treatment

Author: Stern, David F

Source: Expert Opinion on Therapeutic Targets, Volume 9, Number 4, 1 August 2005 , pp. 851-860(10)

Publisher: Informa Healthcare

Buy & download fulltext article:

OR

Price: $99.00 plus tax (Refund Policy)

Abstract:

Reversible protein phosphorylation is one of the most important forms of cellular regulation. For this reason, phosphoproteomic analysis of protein phosphorylation in cells is a powerful tool for evaluating the functional status of cells. The importance of protein kinase-regulated signal transduction pathways in human cancer has led to the development of drugs that inhibit protein kinases at the apex or intermediary levels of these pathways. Phosphoproteomic analysis of these signalling pathways will provide important insights into the operation and connectivity of these pathways that will facilitate the identification of the best targets for cancer therapies. Moreo-ver, phosphoproteomic analysis of individual tumours will help match targeted cancer drugs to the appropriate patients.

Keywords: cancer; kinase; oncology; phosphatase; phosphoproteome; protein phosphorylation; therapeutics

Document Type: Review article

DOI: http://dx.doi.org/10.1517/14728222.9.4.851

Publication date: 2005-08-01

More about this publication?
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page